Present consensus, still to be adequately validated, is that although the lean individuals with type 2 diabetes had a similar pathophysiology concerning their insulin resistance as the obese individual, their insulin secretory defects are much more severe. The gene discussed is INS; the disease is type 2 diabetes mellitus.